Ospedale Uboldo - ASST Melegnano e Martesana
- Address
- lock Available on a paid plan
Ospedale Uboldo - ASST Melegnano e Martesana
Ospedale Uboldo, part of ASST Melegnano e Martesana, is a clinical research center contributing to advanced studies in critical care medicine. The center specializes in investigating novel therapeutic interventions for severe respiratory conditions requiring intensive care management.
- Acute Respiratory Distress Syndrome (ARDS) management and treatment strategies
- Anti-fibrotic therapies in critical respiratory illness
- Ventilator management and mechanical ventilation optimization
The center is actively involved in the PIONEER trial, evaluating the potential of Pirfenidone to prevent pulmonary fibrosis development in patients with Acute Respiratory Distress Syndrome. This research focuses on improving patient outcomes by increasing ventilator-free days, a critical metric in intensive care that reflects both recovery speed and reduced complications associated with prolonged mechanical ventilation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Ospedale San Raffaele S.r.l.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ospedale Uboldo - ASST Melegnano e Martesana
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Pirfenidone in Preventing Fibrosis in Acute Respiratory Distress Syndrome: A Randomized Controlled Trial | Ospedale San Raffaele S.r.l. | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pirfenidone | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.